Skip to main content
Premium Trial:

Request an Annual Quote

Tecan Starts Additional Share Buyback Program

NEW YORK (GenomeWeb News) – On the heels of a just-completed share repurchase program, Tecan has initiated another stock buyback program on the SWX Swiss Exchange.
Männedorf, Switzerland-based Tecan said today that it has completed its share repurchase program on the “first trading line,” which began Jan. 9, 2007, on the SWX Swiss Exchange. During that program, the firm bought 627,287 shares, or 5.2 percent of its share capital.
Tecan said it now owns 1,045,310 — or 8.65 percent — of its share capital.
The laboratory instrument firm will now embark on a second buyback program on a "second trading line," after which the shares will be cancelled and the share capital will be reduced accordingly. It said the program is limited to a maximum of 10 percent of the firm’s share capital.
Thomas Bachmann, CEO of Tecan, said that fiscal year 2007, “with the marked increase in profitability and our strong cash position put us in a position that allows us to pay back excess cash to our shareholders.”

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.